Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
This article was originally published in The Tan Sheet
Executive Summary
Germany’s Merck KGaA could join the ranks of firms like Pfizer potentially looking to leave the consumer health care product business, market analysts argue.
You may also be interested in...
Merck Reaffirms Commitment To Consumer Care In Restructuring
Merck says it remains committed to retaining consumer care and animal health, though it continues to evaluate the businesses. Competitors such as Pfizer and Bristol-Myers Squibb successfully spun out non-pharma assets following similar restructurings.
Merck Reaffirms Commitment To Consumer Care In Restructuring
Merck says it remains committed to retaining consumer care and animal health, though it continues to evaluate the businesses. Competitors such as Pfizer and Bristol-Myers Squibb successfully spun out non-pharma assets following similar restructurings.
Merck Reaffirms Commitment To Consumer Care In Restructuring
Merck says it remains committed to retaining consumer care and animal health, though it continues to evaluate the businesses. Competitors such as Pfizer and Bristol-Myers Squibb successfully spun out non-pharma assets following similar restructurings.